Pharming Group NV (PHAR)
15.62
-0.37
(-2.31%)
USD |
NASDAQ |
Mar 03, 12:29
Pharming Group EPS Diluted (Quarterly) : 0.109 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -1.376 |
| ProQR Therapeutics NV | -0.1221 |
| argenx SE | -- |
| Pharvaris NV | -0.6971 |
| NewAmsterdam Pharma Co. NV | -0.6549 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.466M |
| Revenue (Quarterly) | 96.86M |
| Total Expenses (Quarterly) | 89.39M |
| Enterprise Value | 1.060B |
| Gross Profit Margin (Quarterly) | 92.70% |
| Profit Margin (Quarterly) | 7.71% |
| Earnings Yield | 0.09% |
| Operating Earnings Yield | 3.19% |
| Normalized Earnings Yield | 0.7721 |